SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-22-006086
Filing Date
2022-08-26
Accepted
2022-08-26 16:05:39
Documents
12
Period of Report
2022-08-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT phio_8k.htm   iXBRL 8-K 28553
  Complete submission text file 0001683168-22-006086.txt   200554

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phio-20220825.xsd EX-101.SCH 2965
3 XBRL LABEL FILE phio-20220825_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE phio-20220825_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT phio_8k_htm.xml XML 3602
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 221205202
SIC: 2834 Pharmaceutical Preparations